Purchases and Sales Made in Q3 2024 in Esperion Therapeutics, Inc. (ESPR)
This table provides information about the institutional ownership of Esperion Therapeutics, Inc. (ESPR) during Q3 2024. The information is specifically focused on institutions that hold shares of Esperion Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Oct 28, 2024
Q3 2024
|
New York State Common Retirement Fund
|
SELL
|
- |
-45.1K- 58.95% |
$72.6K - $123K
|
31.4K
$80.7K
|
|
|
Nov 13, 2024
Q3 2024
|
Diametric Capital, LP
Boston, MA |
SELL
|
- |
-77K- 10.35% |
$124K - $210K
|
667K
$1.71M
|
|
|
Nov 07, 2024
Q3 2024
|
Platinum Investment Management LTD
Sydney Australia 2000, C3 |
SELL
|
- |
-104K- 8.66% |
$167K - $283K
|
1.09M
$2.81M
|
|
|
Nov 14, 2024
Q3 2024
|
Graham Capital Management, L.P.
Rowayton, CT |
SELL
|
- |
-104K- 30.51% |
$168K - $285K
|
238K
$611K
|
|
|
Nov 12, 2024
Q3 2024
|
Headlands Technologies LLC
Chicago, IL |
SELL
|
- |
-112K- 40.44% |
$180K - $305K
|
165K
$423K
|
|
|
Nov 14, 2024
Q3 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-128K- 86.7% |
$205K - $348K
|
19.6K
$50.3K
|
|
|
Nov 14, 2024
Q3 2024
|
High Tower Advisors, LLC
Chicago, IL |
SELL
|
- |
-131K- 55.41% |
$211K - $358K
|
106K
$271K
|
|
|
Nov 14, 2024
Q3 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-174K- 7.64% |
$280K - $474K
|
2.1M
$5.39M
|
|
|
Nov 14, 2024
Q3 2024
|
Xtx Topco LTD
London, X0 |
SELL
|
- |
-208K- 57.14% |
$335K - $569K
|
156K
$402K
|
|
|
Nov 14, 2024
Q3 2024
|
Parkman Healthcare Partners LLC
Stamford, CT |
SELL
|
- |
-242K- 21.1% |
$389K - $659K
|
903K
$2.32M
|
|
|
Nov 14, 2024
Q3 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-274K- 7.08% |
$441K - $749K
|
3.6M
$9.25M
|
|
|
Nov 14, 2024
Q3 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-283K- 73.97% |
$455K - $772K
|
99.6K
$256K
|
|
|
Nov 14, 2024
Q3 2024
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-330K- 38.88% |
$531K - $900K
|
518K
$1.33M
|
|
|
Nov 14, 2024
Q3 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-352K- 31.91% |
$567K - $961K
|
751K
$1.93M
|
|
|
Nov 13, 2024
Q3 2024
|
Bank Of Montreal
Toronto, A6 |
SELL
|
- |
-427K- 99.3% |
$687K - $1.17M
|
3.03K
$7.79K
|
|
|
Nov 14, 2024
Q3 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-450K- 11.04% |
$724K - $1.23M
|
3.63M
$9.32M
|
|
|
Nov 13, 2024
Q3 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-508K- 35.71% |
$818K - $1.39M
|
914K
$2.35M
|
|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-683K- 20.51% |
$1.1M - $1.86M
|
2.65M
$6.8M
|
|
|
Nov 14, 2024
Q3 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-1.21M- 28.14% |
$1.95M - $3.31M
|
3.09M
$7.95M
|
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-1.39M- 91.22% |
$2.23M - $3.79M
|
134K
$343K
|
|
|
Nov 14, 2024
Q3 2024
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-2.81M- 55.56% |
$4.52M - $7.66M
|
2.24M
$5.77M
|
|
|
Nov 14, 2024
Q3 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-3.11M- 47.75% |
$5.01M - $8.49M
|
3.4M
$8.75M
|